Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current research toward optimizing dosing of first-line antituberculosis treatment. | Expert Rev Anti Infect Ther | 2019 | 30501530 | PubTator, text mining | PubMed |
| Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy. | Pharmacogenet Genomics | 2019 | 30489456 | PubTator, text mining | PubMed |
| In vivo phenotyping of cytochrome 450 isoforms involved in the metabolism of anti-HIV and anti-tubercular drugs in human using cocktail approach: An LC-MS/MS analysis. | J Pharm Biomed Anal | 2019 | 30472588 | PubTator, text mining | PubMed |
| Butyrate interacts with benzo[a]pyrene to alter expression and activities of xenobiotic metabolizing enzymes involved in metabolism of carcinogens within colon epithelial cell models. | Toxicology | 2019 | 30439556 | PubTator, text mining | PubMed |
| Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib. | Cancer Res Treat | 2019 | 30309221 | PubTator, text mining | PubMed |
| Identification of a five-gene signature with prognostic value in colorectal cancer. | J Cell Physiol | 2019 | 30132881 | PubTator, text mining | PubMed |
| Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. | Clin Pharmacokinet | 2019 | 29752633 | PubTator, text mining | PubMed |
| Genomic Variation and Pharmacokinetics in Old Age: A Quantitative Review of Age- vs. Genotype-Related Differences. | Clin Pharmacol Ther | 2019 | 29498032 | PubTator, text mining | PubMed |
| Age-Related Hearing Impairment Associated NAT2, GRM7, GRHL2 Susceptibility Gene Polymorphisms and Haplotypes in Roma and Hungarian Populations. | Pathol Oncol Res | 2019 | 29455378 | PubTator, text mining | PubMed |
| [Association of rs1495741 Single Nucleotide Polymorphism with Susceptibility of Anti-tuberculosis Drug-induced Hepatotoxicity]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2018 | 32677403 | PubTator, text mining | PubMed |
| Pharmacogenetics: An Important Part of Drug Development with A Focus on Its Application. | Int J Biomed Investig | 2018 | 32467882 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives. | J Clin Transl Res | 2018 | 30873497 | PubTator, text mining | PubMed |
| Modeling Gene-Environment Interaction for the Risk of Non-hodgkin Lymphoma. | Front Oncol | 2018 | 30693270 | PubTator, text mining | PubMed |
| Isoniazid-induced liver disorder in the treatment of tuberculosis. | Chronic Dis Transl Med | 2018 | 30603745 | PubTator, text mining | PubMed |
| Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan. | Molecules | 2018 | 30597998 | PubTator, text mining | PubMed |
| Genetics and genomics in Peru: Clinical and research perspective. | Mol Genet Genomic Med | 2018 | 30584990 | PubTator, text mining | PubMed |
| Study of correlation between the NAT2 phenotype and genotype status among Greenlandic Inuit. | EXCLI J | 2018 | 30564082 | PubTator, text mining | PubMed |
| Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis. | Avicenna J Med Biotechnol | 2018 | 30555665 | PubTator, text mining | PubMed |
| Cytochrome P450 (CYP450,2D6*A), N-Acetyltransferase-2 (NAT2*7, A) and Multidrug Resistance 1 (MDR1 3435 T) Alleles Collectively Increase Risk of Ulcerative Colitis. | Arch Iran Med | 2018 | 30551694 | PubTator, text mining | PubMed |
| The Impact of Coffee and Its Selected Bioactive Compounds on the Development and Progression of Colorectal Cancer In Vivo and In Vitro. | Molecules | 2018 | 30551667 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=54